nodes	percent_of_prediction	percent_of_DWPC	metapath
Finasteride—CYP3A4—Imiquimod—skin cancer	0.148	0.192	CbGbCtD
Finasteride—CYP3A4—Temozolomide—skin cancer	0.148	0.192	CbGbCtD
Finasteride—CYP3A4—Vismodegib—skin cancer	0.102	0.133	CbGbCtD
Finasteride—CYP3A7-CYP3A51P—Docetaxel—skin cancer	0.095	0.124	CbGbCtD
Finasteride—CYP3A7—Docetaxel—skin cancer	0.095	0.124	CbGbCtD
Finasteride—CYP3A4—Vemurafenib—skin cancer	0.081	0.105	CbGbCtD
Finasteride—CYP3A5—Docetaxel—skin cancer	0.0713	0.0928	CbGbCtD
Finasteride—CYP3A4—Docetaxel—skin cancer	0.0278	0.0362	CbGbCtD
Finasteride—Musculoskeletal disorder—Vismodegib—skin cancer	0.0256	0.111	CcSEcCtD
Finasteride—Neoplasm malignant—Vismodegib—skin cancer	0.0107	0.0463	CcSEcCtD
Finasteride—Trauma—Bleomycin—skin cancer	0.0072	0.0311	CcSEcCtD
Finasteride—Neoplasm malignant—Vemurafenib—skin cancer	0.00662	0.0286	CcSEcCtD
Finasteride—Breast disorder—Vismodegib—skin cancer	0.00601	0.0259	CcSEcCtD
Finasteride—Tenderness—Imiquimod—skin cancer	0.00553	0.0239	CcSEcCtD
Finasteride—Breast cancer—Docetaxel—skin cancer	0.00527	0.0227	CcSEcCtD
Finasteride—Neoplasm—Vemurafenib—skin cancer	0.00511	0.0221	CcSEcCtD
Finasteride—Swelling—Imiquimod—skin cancer	0.00397	0.0171	CcSEcCtD
Finasteride—Tenderness—Bleomycin—skin cancer	0.00393	0.017	CcSEcCtD
Finasteride—Injury—Imiquimod—skin cancer	0.00381	0.0164	CcSEcCtD
Finasteride—Breast disorder—Imiquimod—skin cancer	0.00316	0.0137	CcSEcCtD
Finasteride—Tenderness—Fluorouracil—skin cancer	0.00305	0.0132	CcSEcCtD
Finasteride—Influenza—Imiquimod—skin cancer	0.00303	0.0131	CcSEcCtD
Finasteride—Bronchitis—Imiquimod—skin cancer	0.00291	0.0126	CcSEcCtD
Finasteride—Oedema peripheral—Vemurafenib—skin cancer	0.0028	0.0121	CcSEcCtD
Finasteride—Pain—Vismodegib—skin cancer	0.00279	0.0121	CcSEcCtD
Finasteride—Erectile dysfunction—Imiquimod—skin cancer	0.00279	0.012	CcSEcCtD
Finasteride—Injury—Bleomycin—skin cancer	0.00271	0.0117	CcSEcCtD
Finasteride—Neoplasm—Temozolomide—skin cancer	0.00261	0.0113	CcSEcCtD
Finasteride—Sinusitis—Imiquimod—skin cancer	0.00253	0.0109	CcSEcCtD
Finasteride—Rhinitis—Imiquimod—skin cancer	0.00243	0.0105	CcSEcCtD
Finasteride—Pharyngitis—Imiquimod—skin cancer	0.0024	0.0104	CcSEcCtD
Finasteride—Asthenia—Vismodegib—skin cancer	0.00234	0.0101	CcSEcCtD
Finasteride—Pruritus—Vismodegib—skin cancer	0.00231	0.00998	CcSEcCtD
Finasteride—Swelling—Fluorouracil—skin cancer	0.00219	0.00946	CcSEcCtD
Finasteride—Immune system disorder—Imiquimod—skin cancer	0.00219	0.00944	CcSEcCtD
Finasteride—Mental disorder—Imiquimod—skin cancer	0.00212	0.00916	CcSEcCtD
Finasteride—Rash—Vismodegib—skin cancer	0.00206	0.00889	CcSEcCtD
Finasteride—Dermatitis—Vismodegib—skin cancer	0.00206	0.00888	CcSEcCtD
Finasteride—Infection—Vemurafenib—skin cancer	0.002	0.00865	CcSEcCtD
Finasteride—Angioedema—Imiquimod—skin cancer	0.00193	0.00832	CcSEcCtD
Finasteride—Breast disorder—Temozolomide—skin cancer	0.0019	0.00819	CcSEcCtD
Finasteride—Hypotension—Vemurafenib—skin cancer	0.00189	0.00814	CcSEcCtD
Finasteride—Bronchitis—Temozolomide—skin cancer	0.00174	0.00753	CcSEcCtD
Finasteride—Neoplasm—Docetaxel—skin cancer	0.00174	0.0075	CcSEcCtD
Finasteride—Infection—Imiquimod—skin cancer	0.00171	0.00738	CcSEcCtD
Finasteride—Erectile dysfunction—Temozolomide—skin cancer	0.00167	0.00721	CcSEcCtD
Finasteride—Pharyngitis—Dactinomycin—skin cancer	0.00159	0.00688	CcSEcCtD
Finasteride—Swelling—Docetaxel—skin cancer	0.00158	0.00683	CcSEcCtD
Finasteride—Dyspnoea—Imiquimod—skin cancer	0.00153	0.00662	CcSEcCtD
Finasteride—Somnolence—Imiquimod—skin cancer	0.00153	0.0066	CcSEcCtD
Finasteride—Sinusitis—Temozolomide—skin cancer	0.00152	0.00655	CcSEcCtD
Finasteride—Hypersensitivity—Vemurafenib—skin cancer	0.00149	0.00642	CcSEcCtD
Finasteride—Pain—Imiquimod—skin cancer	0.00147	0.00635	CcSEcCtD
Finasteride—Asthenia—Vemurafenib—skin cancer	0.00145	0.00625	CcSEcCtD
Finasteride—Pharyngitis—Temozolomide—skin cancer	0.00144	0.00622	CcSEcCtD
Finasteride—Oedema peripheral—Temozolomide—skin cancer	0.00143	0.00617	CcSEcCtD
Finasteride—Pruritus—Vemurafenib—skin cancer	0.00143	0.00616	CcSEcCtD
Finasteride—Sinusitis—Fluorouracil—skin cancer	0.0014	0.00603	CcSEcCtD
Finasteride—Urticaria—Imiquimod—skin cancer	0.00137	0.0059	CcSEcCtD
Finasteride—Rhinitis—Fluorouracil—skin cancer	0.00134	0.00579	CcSEcCtD
Finasteride—Dizziness—Vemurafenib—skin cancer	0.00133	0.00576	CcSEcCtD
Finasteride—Pharyngitis—Fluorouracil—skin cancer	0.00133	0.00573	CcSEcCtD
Finasteride—Immune system disorder—Temozolomide—skin cancer	0.00131	0.00566	CcSEcCtD
Finasteride—Orthostatic hypotension—Docetaxel—skin cancer	0.00127	0.0055	CcSEcCtD
Finasteride—Rash—Vemurafenib—skin cancer	0.00127	0.00549	CcSEcCtD
Finasteride—Mental disorder—Temozolomide—skin cancer	0.00127	0.00549	CcSEcCtD
Finasteride—Dermatitis—Vemurafenib—skin cancer	0.00127	0.00549	CcSEcCtD
Finasteride—Hypersensitivity—Imiquimod—skin cancer	0.00127	0.00547	CcSEcCtD
Finasteride—Headache—Vemurafenib—skin cancer	0.00126	0.00546	CcSEcCtD
Finasteride—Breast disorder—Docetaxel—skin cancer	0.00126	0.00544	CcSEcCtD
Finasteride—Asthenia—Imiquimod—skin cancer	0.00123	0.00533	CcSEcCtD
Finasteride—Pruritus—Imiquimod—skin cancer	0.00122	0.00526	CcSEcCtD
Finasteride—Infection—Bleomycin—skin cancer	0.00121	0.00524	CcSEcCtD
Finasteride—Angioedema—Temozolomide—skin cancer	0.00115	0.00498	CcSEcCtD
Finasteride—Hypotension—Bleomycin—skin cancer	0.00114	0.00493	CcSEcCtD
Finasteride—Dizziness—Imiquimod—skin cancer	0.00114	0.00491	CcSEcCtD
Finasteride—Infection—Dactinomycin—skin cancer	0.00113	0.00489	CcSEcCtD
Finasteride—Dyspnoea—Bleomycin—skin cancer	0.00109	0.00471	CcSEcCtD
Finasteride—Rash—Imiquimod—skin cancer	0.00109	0.00468	CcSEcCtD
Finasteride—Dermatitis—Imiquimod—skin cancer	0.00108	0.00468	CcSEcCtD
Finasteride—Headache—Imiquimod—skin cancer	0.00108	0.00465	CcSEcCtD
Finasteride—Pain—Bleomycin—skin cancer	0.00105	0.00451	CcSEcCtD
Finasteride—Infection—Temozolomide—skin cancer	0.00102	0.00442	CcSEcCtD
Finasteride—Pain—Dactinomycin—skin cancer	0.000975	0.00421	CcSEcCtD
Finasteride—Urticaria—Bleomycin—skin cancer	0.000971	0.00419	CcSEcCtD
Finasteride—Rhinitis—Docetaxel—skin cancer	0.000968	0.00418	CcSEcCtD
Finasteride—Pharyngitis—Docetaxel—skin cancer	0.000958	0.00414	CcSEcCtD
Finasteride—Oedema peripheral—Docetaxel—skin cancer	0.000951	0.0041	CcSEcCtD
Finasteride—Infection—Fluorouracil—skin cancer	0.000944	0.00407	CcSEcCtD
Finasteride—Dyspnoea—Temozolomide—skin cancer	0.000919	0.00397	CcSEcCtD
Finasteride—Somnolence—Temozolomide—skin cancer	0.000917	0.00396	CcSEcCtD
Finasteride—Hypersensitivity—Bleomycin—skin cancer	0.000901	0.00389	CcSEcCtD
Finasteride—Hypotension—Fluorouracil—skin cancer	0.000888	0.00383	CcSEcCtD
Finasteride—Pain—Temozolomide—skin cancer	0.000882	0.00381	CcSEcCtD
Finasteride—Asthenia—Bleomycin—skin cancer	0.000877	0.00379	CcSEcCtD
Finasteride—Immune system disorder—Docetaxel—skin cancer	0.000872	0.00376	CcSEcCtD
Finasteride—Pruritus—Bleomycin—skin cancer	0.000865	0.00373	CcSEcCtD
Finasteride—Dyspnoea—Fluorouracil—skin cancer	0.000847	0.00366	CcSEcCtD
Finasteride—Mental disorder—Docetaxel—skin cancer	0.000846	0.00365	CcSEcCtD
Finasteride—Somnolence—Fluorouracil—skin cancer	0.000845	0.00365	CcSEcCtD
Finasteride—Hypersensitivity—Dactinomycin—skin cancer	0.00084	0.00363	CcSEcCtD
Finasteride—Urticaria—Temozolomide—skin cancer	0.000819	0.00354	CcSEcCtD
Finasteride—Asthenia—Dactinomycin—skin cancer	0.000818	0.00353	CcSEcCtD
Finasteride—Pain—Fluorouracil—skin cancer	0.000813	0.00351	CcSEcCtD
Finasteride—Rash—Bleomycin—skin cancer	0.000771	0.00333	CcSEcCtD
Finasteride—Dermatitis—Bleomycin—skin cancer	0.00077	0.00332	CcSEcCtD
Finasteride—Hypersensitivity—Temozolomide—skin cancer	0.00076	0.00328	CcSEcCtD
Finasteride—Urticaria—Fluorouracil—skin cancer	0.000755	0.00326	CcSEcCtD
Finasteride—Asthenia—Temozolomide—skin cancer	0.00074	0.00319	CcSEcCtD
Finasteride—Pruritus—Temozolomide—skin cancer	0.00073	0.00315	CcSEcCtD
Finasteride—Rash—Dactinomycin—skin cancer	0.000719	0.0031	CcSEcCtD
Finasteride—Hypersensitivity—Fluorouracil—skin cancer	0.0007	0.00302	CcSEcCtD
Finasteride—Dizziness—Temozolomide—skin cancer	0.000682	0.00294	CcSEcCtD
Finasteride—Infection—Docetaxel—skin cancer	0.000681	0.00294	CcSEcCtD
Finasteride—Pruritus—Fluorouracil—skin cancer	0.000672	0.0029	CcSEcCtD
Finasteride—Rash—Temozolomide—skin cancer	0.00065	0.00281	CcSEcCtD
Finasteride—Dermatitis—Temozolomide—skin cancer	0.00065	0.0028	CcSEcCtD
Finasteride—Headache—Temozolomide—skin cancer	0.000646	0.00279	CcSEcCtD
Finasteride—Hypotension—Docetaxel—skin cancer	0.000641	0.00277	CcSEcCtD
Finasteride—Dizziness—Fluorouracil—skin cancer	0.000628	0.00271	CcSEcCtD
Finasteride—Dyspnoea—Docetaxel—skin cancer	0.000611	0.00264	CcSEcCtD
Finasteride—Somnolence—Docetaxel—skin cancer	0.00061	0.00263	CcSEcCtD
Finasteride—Rash—Fluorouracil—skin cancer	0.000599	0.00259	CcSEcCtD
Finasteride—Dermatitis—Fluorouracil—skin cancer	0.000599	0.00258	CcSEcCtD
Finasteride—Headache—Fluorouracil—skin cancer	0.000595	0.00257	CcSEcCtD
Finasteride—Pain—Docetaxel—skin cancer	0.000587	0.00253	CcSEcCtD
Finasteride—Hypersensitivity—Docetaxel—skin cancer	0.000505	0.00218	CcSEcCtD
Finasteride—Asthenia—Docetaxel—skin cancer	0.000492	0.00212	CcSEcCtD
Finasteride—Pruritus—Docetaxel—skin cancer	0.000485	0.00209	CcSEcCtD
Finasteride—Dizziness—Docetaxel—skin cancer	0.000454	0.00196	CcSEcCtD
Finasteride—Rash—Docetaxel—skin cancer	0.000432	0.00187	CcSEcCtD
Finasteride—Dermatitis—Docetaxel—skin cancer	0.000432	0.00186	CcSEcCtD
Finasteride—Headache—Docetaxel—skin cancer	0.00043	0.00185	CcSEcCtD
